|
|||||
A university spin-off enterprise is receiving funds from National Institute of Mental Health to develop a simple, reliable electronic device to evaluate effects of neurological drugs on brain cells. . . . → Read More: NIH Supporting Electronic Neuro Drug Test Technology 
Drug maker AbbVie and biotechnology company Morphic Therapeutic are collaborating on new treatments for fibrosis based on Morphic’s technology blocking proteins that promote fibrosis. . . . → Read More: Harvard Spin-Off, AbbVie Partner on Fibrosis Treatments 
A new clinical trial is testing the drug semaglutide for people with type 2 diabetes against as many as 40 other diabetes treatments when used as a supplemental drug over 2 years. . . . → Read More: Diabetes Drug Assessed Long-Term Against All Other Treatments 
A synthetic antibody is shown in tests with lab mice to block the blood protein fibrin from causing inflammation and related damage to brain cells found in neurodegenerative diseases. . . . → Read More: Antibody Designed to Stop Inflammation Protein in Brain 
Two clinical trials testing synthetic antibodies designed to treat blood-related cancers were stopped by their developer after a participant in one trial died from adverse effects. . . . → Read More: Cancer Antibody Trials Stopped After Patient Death 
Research with lab mice shows prenatal genome editing with techniques including Crispr can correct an inherited defect associated with a fatal congenital liver disorder. . . . → Read More: Prenatal Genome Edits Prevent Inherited Liver Disorder  Comments are closed  New products  biomedical, biotechnology, genomics, life sciences, pharmaceuticals, preclinical, university 
A start-up enterprise founded by medical researchers in the U.S. and Europe is developing treatments for cancer and autoimmune disorders that change chemical reactions in immune system cells. . . . → Read More: Start-Up Developing Immunometabolism Therapies, Gains $30M Funding Comments are closed Finance, Intellectual property biomedical, biotechnology, cancer, chemistry, entrepreneurs, equity, Europe, investment, licensing, life sciences, pharmaceuticals, physical sciences, university, venture capital 
A series of clinical trials are planned to test the use of adult stem cells to treat injuries to the eyes that lead to vision loss. . . . → Read More: Trials to Test Stem Cell Treatments for Eye Injuries One comment - (Comments are closed) Finance, New products biomedical, biotechnology, clinical trials, DoD, grant, life sciences, pharmaceuticals, stem cells, university 
A biotechnology company developing therapies that silence the actions of disease-causing genes is licensing its treatment program for hepatitis-B to Janssen Pharmaceuticals. . . . → Read More: Biotech in $3.7B Licensing Deal for Hepatitis-B One comment - (Comments are closed) Finance, Intellectual property biomedical, biotechnology, clinical trials, equity, genomics, investment, licensing, life sciences, pharmaceuticals 
An academic-industry team in Europe and Central America assembled a group of human antibodies that protects lab mice against venomous toxins from a dangerous African snake. . . . → Read More: Human Antibodies Devised for Snakebite Treatment 2 comments - (Comments are closed) Joint ventures/collaborations, New products Africa, biomedical, biotechnology, Europe, life sciences, pharmaceuticals, preclinical, U.K., university |
One Blood Test Fits All Diseases A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
||||
|
Copyright © 2018 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
